Dotmatics is pleased to offer our industry-leading electronic lab notebook solution in a simple hosted edition design to allow small research teams to jump-start their discovery journey. This offering provides the exact same Dotmatics Studies Notebook solution used enterprise-wide by hundreds of research organizations and thousands of scientists worldwide to capture their experiments, secure their IP and collaborate on their projects. The eln.online edition features a standard template to capture general discovery experiments as well as a template designed for medicinal & synthetic chemistry experiments.
Starting up a new biotech is very exciting but challenging at the same time.
Getting started with an ELN is as simple as deciding whether to run the company on Google Docs or Office 365!
Steve Gallagher CEO, Dotmatics, shares his thoughts on why every startup founder should choose an ELN rather than settle for a compromise like spreadsheets, reports and email, even for a short while.continue reading
eln.online is available to organizations that:
*unless upgrading to Dotmatics Studies ELN during the year.
Chinook Therapeutics adopted the Dotmatics Studies Notebook in our early stages of R&D”, said Tao Sheng, Scientist II. “We were able to get up and running with the ELN very quickly and easily and this ensured that we could immediately capture and collaborate on our experiments and make sure our IP was secure. Since then we have grown and expanded our scientific programs, and the ELN has grown with us at every step. Dotmatics’ new eln.online offering should make it even easier for start-up companies to be up and running with an ELN the moment they first start on their research efforts.Tao Sheng
Scientist II, Chinook Therapeutics
We’re thrilled to offer this new ELN to support start-ups and provide a strong technology platform as a springboard to expansion. ELNs are an essential part of lab and IT infrastructure and so we have worked hard to deliver a product that can be set up and established quickly and early in a company's development to ensure they are able to maximize productivity and safeguard their IP from day one.Dr. Stephen Gallagher